Madden Martin J. - Jun 9, 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Director
Signature: By: /s/ Steven Robbins, Attorney in Fact for Martin J. Madden
Stock symbol: NVCR
Transactions as of: Jun 9, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/11/2021, 04:22 PM
Next filing: Aug 6, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Restricted Stock Units	Award	$0	+814	+5.5%	$0.00	15.6K	Jun 9, 2021	Direct	F1
holding	NVCR	Ordinary Shares						418	Jun 9, 2021	Indirect	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Options to Buy Ordinary Shares	Award	$0	+1.5K		$0.00	1.5K	Jun 9, 2021	Ordinary Shares	1.5K	$211.89	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.
F2	Represents shares indirectly beneficially owned by Mr. Madden that are held by his child with whom he shares a residence. Mr. Madden disclaims beneficial ownership of these shares.
F3	Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.